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Quantitative Evaluation of 
Liver Function with MRI Using 
Gd-EOB-DTPA
Objective: Gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-
EOB-DTPA) is a newly developed MR contrast agent. After intravenous injection,
Gd-EOB-DTPA is gradually taken up by the hepatocytes and eventually excreted
via the biliary pathway without any change to its chemical structure. Because of
these characteristics, it can be used as a tracer for quantitative liver function test-
ing. The purpose of this study is to develop a noninvasive method of quantitation
of the hepatic function using Gd-EOB-DTPA through the deconvolution analysis.
Materials and Methods: Adult New Zealand white rabbits (n = 10, average
body weight = 3.5 kg) were used in the present study. Hepatic injury was induced
to by the intragastric administration of carbon tetrachloride (CCl4) three times a
week for three weeks. Liver enzyme (aspartate aminotransferase, AST; alanine
aminotransferase, ALT) levels and the plasma indocyanine green (ICG) retention
rate 15 minutes after an intravenous injection of ICG (ICG R15), was checked
before and after the three-week administration of CCl4. At the end of experimen-
tal period, an observer  “blinded” to the treatment given the rabbits performed the
histological examination. MRI studies were performed before and after the three-
week administration of CCl4 on a 1.5 T scanner using a human extremity coil.
After intravenous bolus injection of Gd-EOB-DTPA (0.3 mL of Gd-EOB-DTPA
freshly prepared in 2.7 mL of normal saline) through the ear vein, the 250 axial
single level dynamic MR images were obtained using a fast low angle shot
(FLASH, TR/TE = 11/4.2 msec, flip angle = 15, acquisition time 1 second, slice
thickness = 5 mm, matrix = 128×128, field of view = 120 mm) sequence with 1.5
sec time intervals. The time-intensity curves were obtained at the abdominal
aorta and the liver parenchyma that was devoid of blood vessels. Deconvolution
analysis of the aortic (input function) and hepatic parenchymal (output function)
time-intensity curves was performed with a modified Fourier transform technique
to calculate the hepatic extraction fraction (HEF). The presence and type of
hepatic injury were determined by the histopathologic examination and statistical
analysis of the changes of the hepatic enzyme levels, the ICG R15 and Gd-EOB-
DTPA HEF values between the time before and after CCl4 administration with
Wicoxon signed rank test. Correlation between the Gd-EOB-DTPA HEF and the
change of the ICG R15 were analyzed with Pearson’ s correlation coefficient. 
Results: Histopathologic examination showed findings that were compatible
with hepatic fibrosis caused by chronic liver injury. The initial blood biochemical
studies before the administration of carbon tetrachloride showed that the mean
AST and ALT levels were 39.8±5.2 IU/L and 59.1±11.7 IU/L, respectively. The
AST and ALT levels increased to 138.4±50.5 IU and 172.0±71.6 IU/L, respec-
tively, after the three week administration of CCl4. The ALT and AST levels were
significantly increased after the three weeks of CCl4 administration (p = 0.018).
The ICG R15 values were 4.47±2.08% and 19.43±3.98% before and after
three-week administration of CCl4, respectively. The ICG R15 values were signif-
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e-mail: hkryeom@knu.ac.krstimation of the hepatic functional reserve is
an essential procedure for preventing postop-
erative hepatic failure and for the medical
management of patients with hepatic dysfunction.
Resection of a large volume of the liver may result in
postoperative liver failure; therefore, the precise estima-
tion of the functional capacity of the whole liver or future
remnant liver is important. The liver function is generally
assessed by quantitative blood level measurements of
liver enzymes such as the aminotransferases. However,
the measurement of liver enzymes reflects an escape of
these enzymes from the liver cells, and this is only an
indirect measurement of hepatocyte injury (1, 2). The
measurement of liver enzymes does not directly reflect
hepatocyte function. The liver carries out thousands of
biochemical functions (3). It has a virtually infinite
capacity for regeneration, and this further complicates
quantitative assessment of the hepatic function reserve. In
fact, approximately half of its mass can be excised with
only a transient change being noted on the contemporary
liver function tests (3). For these reasons, it is desirable to
have a direct measurement of hepatocyte function, and
many indices have been proposed for this purpose (4-8).
Recently, the indocyanine green (ICG) plasma clearance
test is the most commonly used test for the preoperative
evaluation of liver function (9). However, it can occasion-
ally be an unreliable index because the hepatic uptake of
ICG is affected by several unpredictable factors (10-13).
Evaluating the early phase of ICG plasma disappearance
or its direct measurement in the liver has been reported to
be more accurate for the estimation of liver function (14).
Measuring the hepatic extraction fraction (HEF) of a
hepatobiliary radiopharmaceutical agent helps to evaluate
hepatic function, and this is generally performed using
deconvolution analysis (15). A scintigraphy technique
with deconvolution analysis has recently been proposed as
a direct intrahepatic measurement of the early phase
metabolism of an organic anion, Tc-99m diisopropyl
imminodiacetic acid (Tc-99m DISIDA) (16). In this study,
the authors developed a noninvasive technique to quanti-
tate the hepatocyte function in rabbits using deconvolu-
tion analysis of the dynamic MR images obtained after the
administration of a liver-specific contrast agent for the MR
imaging, gadolinium-ethoxybenzyl-diethylenetriamine-
pentaacetic acid (Gd-EOB-DTPA).
MATERIALS AND METHODS
Hepatic Injury Model
Ten adult New Zealand white rabbits (average body
weight = 3.5 kg) were used in this study. The animals were
allowed to adapt to the animal care facility for one week,
and they were given free access to standard rabbit chow
and tap water. Hepatic injury was induced by the intragas-
tric administration of carbon tetrachloride (CCl4) three
times a week for three weeks. The dose of CCl4 was 0.4
ml/kg and it was administered after mixing it with 1.6
ml/kg of olive oil. During the period of CCl4 administra-
tion, three rabbits died, probably of hepatic failure (n = 1)
and other undetermined causes (n = 2). 
Biochemical Tests and Histopathologic Examinations
Aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) levels were checked before and
three weeks after starting the CCl4 administration.
Indocyanine green (ICG) clearance testing was performed
in all animals before and at the end of CCl4 administration
as an index of the liver function. A single dose of ICG (0.5
mg/kg; Diagnogreen Inj., Diichi Pharmaceutical Co., Tokyo,
Japan) was freshly prepared in saline and then injected into
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icantly increased after hepatic injury (p = 0.018). After normalizing the HEF as
100% in each rabbit before CCl4 administration, the deconvoluted curve after
CCl4 administration revealed less hepatocyte extraction efficiency with a mean
value of 77.7±3.6. There was a significant correlation between the HEF and
changes of the ICG R15 by the Pearson correlation coefficient assessment (cor-
relation coefficient = -0.965, p = 0.000). 
Conclusion: The Gd-EOB-DTPA HEF could be calculated from deconvolution
analysis of aortic and hepatic parenchymal time-intensity curves obtained by
dynamic MRI. The Gd-EOB-DTPA HEF was well correlated with changes of the
ICG R15, which is the most common parameter used in the quantitative estima-
tion of the hepatic function. The Gd-EOB-DTPA HEF is a direct, noninvasive
technique for the quantitative evaluation of liver function. It could be a promising
alternative for the determination of noninvasive hepatic function in those patients
with liver disease. 
Ean ear vein. Blood samples (3 mL) were collected into tubes
containing EDTA before and 15 minutes after the ICG
administration. The samples were centrifuged at 2000 g for
four minutes, and the plasma was separated and stored at -
20℃ until assay. The plasma ICG concentration (the ICG
retention rate 15 minutes after an intravenous injection,
ICG R15) was determined using an U2001 spectropho-
tometer (Hitachi, Kyoto, Japan) at 805 nm. 
For the histopathologic examination, the rabbits were
sacrificed at the end of the experimental period with an
overdose (90 mg/kg) of sodium pentobarbital (Dai Han
Pharm. Co., Seoul, Korea). Three fragments from each of
the liver lobes were collected and processed for light
microscopy. The tissues were fixed in 10% formalin and
they were then embedded in paraffin. Serial sections were
cut and stained with hematoxylin-eosin and Masson’ s
trichrome stain. An observer, who was blinded to the
treatment protocol, performed the histological examination. 
MR Imaging
Dynamic MR imaging using Gd-EOB-DTPA (Evovist
�,
Schering, Berlin, Germany) was performed on the rabbits
before and after the three-week administration of CCl4.
All the MRI studies were performed on a 1.5T MR
scanner (Vision Plus, Siemens Medical System, Erlangen,
Germany) with the human extremity coil. The animals
were anesthetized with an intramuscular injection of
ketamine (35 mg/kg) and xylazine (5 mg/kg). The initial
coronal T1-weighted images were obtained with a turbo
fast low angle shot (turbo-FLASH) sequence (TR/TE =
11/4.2 msec, flip angle = 15) for the localization of the
liver. On the basis of these coronal images, an optimal
level that could give the best visualization of the liver and
the abdominal aorta was chosen for repeated axial scans.
The other imaging parameters were: slice thickness of 5
mm, matrix size of 128×128, and field of view (FOV) of
120 mm. After an intravenous bolus injection of Gd-EOB-
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Fig. 1. MR imaging and time-intensity curves.
A. After intravenous injection of Gd-EOB-DTPA, 250 level
dynamic MR imagings were obtained using a turbo-fast low
angle shot (turbo-FLASH) sequence (TR/TE = 11/4.2 msec,
flip angle = 15, acquisition time 1 second, interscan gap = 1.5
second). 
B. Time-intensity curves of aorta and hepatic parenchyma in
a rabbit that were obtained before administration of CCl4.
C. Time-intensity curves of aorta and hepatic parenchyma in
a rabbit that were obtained three weeks after administration
of CCl4.
AB
CDTPA (0.3 mL of Gd-EOB-DTPA freshly prepared in 2.7
mL of normal saline) through the ear vein, the 250 axial
single level dynamic MR images were obtained using the
turbo-FLASH sequence (TR/TE = 11/4.2 msec, flip angle =
15, acquisition time: 1 second) with 1.5 sec time intervals
(Fig. 1A). The bolus injection was finished within 3
seconds and the MR acquisition was started immediately
after this injection. The time-intensity curves were
obtained at the abdominal aorta and at the liver
parenchyma that was devoid of blood vessels (Figs. 1B,
C). For the time-intensity curves, the region of interest
(ROI) of 9 mm
2 was placed on abdominal aorta and liver
parenchyma, and the absolute signal intensities were then
measured. 
Deconvolution Analysis
After the intravenous injection, the Gd-EOB-DTPA,
which is bound to albumin due to its lipophilic nature, is
gradually taken up by the hepatocytes and eventually
excreted via the biliary pathway. Since Gd-EOB-DTPA
does not change its chemical structure during circulation, it
can be used as tracer for quantitative liver function testing.
In addition, the Gd-EOB-DTPA is taken up many times
because of the recirculation of the hepatic blood flow.
Therefore, to quantitate the hepatocyte function, we
needed to introduce a convolution model. The concept of
convolution is that if we measure the time dependent
change of tracer concentration at the last point of the
tracer within a finite distance, the final concentration at the
last point was affected by the concentration at the initial
point and the response function of the interval.
Mathematically, it can be expressed as follow.
g(t) = f(t)*h(t) = ∫f(x)h(t-x)dx
Where f(t) is the input function, which is a tracer concen-
tration at the initial point and g(t) is the output function,
which is a tracer concentration at the last point of the
interval. H(t) is the response function of the interval and
the symbol (*) means convolution of the two functions. In
the integral transform of the convolution, both x and t are
time variables. Therefore, if we know f(t) and g(t), then the
response function, h(t), can be obtained by deconvolution.
To extract the liver response function, the deconvolu-
tion analysis of the aortic (input function) and hepatic
parenchymal (output function) time-intensity curves was
performed with a modified Fourier transform technique.
That is, by measuring the initial input function to the liver
and the early phase liver signal intensities, it is possible to
extract the hepatic extraction fraction by deconvoluting
the early phase liver signal intensities with the aortic
signal intensity. Both the aorta and liver curves are
extended to many times their original length by append-
ing a low-frequency, smoothly tapering curve to the
original data series to compensate for any high-frequency
artifact caused by the abrupt termination of data input at
the conclusion of the imaging procedure. Finally, the
inverse Fourier transform was performed and the
resultant deconvoluted curve, which represents the true
liver response, was obtained. An exponential curve of
best fit was applied to the deconvoluted liver curve and
the y-intercept of this curve was used as representing the
hepatic extraction fraction (Fig. 2). In each rabbit, the HEF
change after CCl4 administration was calculated by
normalizing the HEF before CCl4 administration as
100%.
Ryeom et al.
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Fig. 2. Deconvolution analysis and Gd-EOB-DTPA hepatic extraction fraction.
A. Diagram representing the process of deconvolution analysis. Deconvolution analysis of the aortic (input function) and hepatic
parenchymal (output function) time-intensity curves was performed with a modified Fourier transform technique.
B. The Gd-EOB-DTPA hepatic extraction fraction after hepatic injury was obtained by normalizing the hepatic extraction fraction of
before CCl4 administration as 100% in each rabbit.
ABData Analysis
The presence and type of hepatic injury were determined
by the histopathologic findings, the levels of the serum
enzymes and the ICG R15 value. In each rabbit, the ICG
R15 value was correlated with the hepatic extraction
fraction measured by MRI using Gd-EOB-DTPA (Gd-EOB-
DTPA HEF). The Wilcoxon signed rank test was used to
determine the difference of the liver enzyme levels and
ICG R15 values before and after the administration of
CCl4. The 95% confidence level, p≤0.05, was used to
determine a statistically significant difference. Correlation
between the Gd-EOB-DTPA HEF and the hepatic enzyme
changes and that between the Gd-EOP-DTPA HEF and the
ICG R15 change were assessed using the Pearson correla-
tion coefficient. 
RESULTS
On the histopathologic examination with hematoxylin-
eosin and Masson’ s trichrome stain, chronic inflammatory
cell infiltration was noted around the periportal area, and
there was also periportal fibrosis. These findings were
compatible with hepatic fibrosis due to chronic liver injury
(Fig. 3)
The baseline blood biochemical studies performed before
the administration of CCl4 showed that the mean AST and
ALT levels were 39.8±5.2 IU/L and 59.1±11.7 IU/L,
respectively. After the three-week intragastric administra-
tion of CCl4, the AST and ALT levels increased to 138.4±
50.5 IU and 172.0±71.6 IU/L, respectively, (Table 1). The
increase of the enzyme levels and histopathologic results
MRI Using Gd-EOB-DTPA Liver Function Evaluation
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Table 1. Results of Blood Aminotransferase Levels, ICG R15, and Gd-EOB DTPA Hepatic Extraction Fraction
Animal No. 
AST (IU/L) ALT (IU/L) ICG R15(%) HEF %*
Preinjury Postinjury Preinjury Postinjury Preinjury Postinjury Postinjury
13 3 067 42 205 2.80 20.72 74.6
2 43 178 71 279 2.27 22.45 72.5
3 36 143 59 078 4.65 24.32 77.8
4 44 196 72 107 8.42 15.21 820.
5 41 145 65 194 4.24 21.54 79.6
63 5 072 60 122 3.32 18.47 75.9
7 47 168 45 219 5.64 13.31 81.5
Mean±SD 39.85±5.24 138.42±50.55 59.14±11.79 172±71.63 4.47±2.08 19.43±3.98 77.7±3.56
Note.─ * Relative Gd-EOB-DTPA hepatic extraction fraction calculated after normalizing the hepatic extraction fraction for before CCl4 administration as
100% in each rabbit. AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, ICG: Indocyanine green, HEF: hepatic extraction fraction 
Fig. 3. Histopathologic findings.
A. Photomicrograph of the liver tissue obtained at the end of experiment shows the chronic inflammatory cell infiltration at the portal and
periportal areas (H & E stain; original magnification, ×100).
B. On Masson’ s trichrome stain, note the periportal fibrosis (original magnification, ×100). 
ABconfirmed the chronic hepatic injury. According to the
results of the Wilcoxon signed rank test, there was a signif-
icant difference between ALT and AST levels measured
before and after the administration of CCl4 at the 95%
confidence level (p = 0.018). 
The ICG R15 values before the administration of CCl4
were 4.47±2.08%. After the three-week administration of
CCl4 these values increased to 19.43±3.98% (Table 1).
According to the results of the Wilcoxon signed rank test,
there was a significant difference between the ICG R15
values that were checked before and after the administra-
tion of CCl4 at the 95% confidence level (p = 0.018). 
Due to the recirculation of Gd-EOB-DTPA, the aorta
curve showed small residual signals after the first pass of
the contrast agent. However, the calculation of the hepatic
response function, by means of deconvolution analysis,
corrected the liver time-intensity curve for the constantly
changing blood concentration of the contrast agent that
was presented to the liver at each moment in time, thus
compensating for the systemic recirculation of the agent.
Therefore, the resulting hepatic response function
mathematically simulates a single bolus injection of
contrast agent directly into the hepatic artery. After
normalizing the HEF as being 100% in each rabbit before
the CCl4 administration, the deconvoluted curves of the
dysfunction group after CCl4 administration revealed a
reduced hepatocyte extraction efficiency, with a mean
value of 77.7±3.6% (Table 1). According to the results of
the Wilcoxon signed rank test, there was a significant
difference between the HEF calculated before and after the
administration of CCl4 at the 95% confidence level (p =
0.018). 
The results of Gd-EOB-DTPA HEF were well correlated
with the ICG R15 increase. There was a significant correla-
tion between the HEF and the changes of ICG R15 before
and after the administration of CCl4 as accessed by the
earson correlation coefficient (correlation coefficient =
0.965, p = 0.000) (Fig. 4). However, no statistically signifi-
cant correlation was observed between the changes of the
ICG R15 and the changes of the liver enzyme levels (AST,
correlation coefficient = -0.252, p = 0.568; ALT, correla-
tion coefficient = 0.310, p = 0.499). 
DISCUSSION
There have been many indices proposed for the estima-
tion of hepatic functional reserve (4-8). The ICG plasma
clearance test has been employed with increasing
frequency because ICG, a tricarbocyanine dye, has no
reported toxicity and it undergoes neither intrahepatic
conjugation nor enterohepatic circulation, and it is
removed from the blood stream exclusively by the liver
(4). However, it can occasionally be an unreliable index
because hepatic uptake of ICG is affected by the hepatic
blood flow, the ICG binding lipoprotein in the blood and
the exchange of ICG across the hepatocellular membrane
(10-13). For this reason, evaluation of the early phase of
ICG plasma disappearance or its direct measurement in the
liver is desired for an estimation of the  “purer” liver
function (14). The scintigraphy technique with deconvolu-
tion analysis has recently been proposed as a direct
intrahepatic measurement of the early phase metabolism of
an organic anion, DISIDA (16). In this current study, the
authors have developed a noninvasive technique to quanti-
tate hepatocyte function in rabbits by using a deconvolu-
tion analysis of the dynamic MR images that were obtained
after administration of a liver-specific contrast agent for
the MRI. 
In this study, CCl4 was used to induce chronic liver
disease in the rabbits. Many agents have been used as
hepatotoxins. In previous experiment, the most common
method of producing experimental cirrhosis has been
administering multiple doses of CCl4 (17). As with chloro-
form and halothane, CCl4 requires activation by oxidases
that are involved in the hemolytic breakage of the C-Cl
bond. This activation occurs in the hepatic endoplasmic
reticulum via an enzyme system of electron transport from
reduced nicotinamide adenine dinucleotide phosphate
(NADPH) to oxygen, and this leads to formation of a
reactive metabolite, the trichloromethyl radical (CCl3).
The CCl3 then binds covalently to a series of molecular
Ryeom et al.
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Fig. 4. Scattergram shows the relationship between the Gd-EOB-
DTPA hepatic extraction fraction and the changes of indocyanine
green R15 before and after hepatic injury. The Gd-EOB-DTPA
hepatic extraction fraction decreased as the indocyanine green
R15 values increased (correlation coefficient = -0.965, p = 0.000,
Pearson correlation coefficient assessment). structures, and particularly to the lipid of endoplasmic
reticulum membranes; this initiates lipid peroxidation that
reacts with the sulphydryl groups of the cellular proteins.
Because the acute toxicity of CCl4 is dependent upon its
metabolism by the microsomal hydroxylating hepatic
system, inducers of cytochrome p450, such as ethanol or
phenobarbitone, can potentiate this toxicity (18-20). The
feasibility of using CCl4 for the experimentally induced
chronic liver disease has been well described by Brandao
et al. (21). The time they required for the development of
cirrhosis was relatively long (6 months). In this study, the
CCl4 administration period was reduced to three weeks by
increasing the dosage. Three of the animals died during the
CCl4 administration period, and this was probably because
of acute hepatic failure (n = 1) and other uncertain causes
(n = 2), yet it was possible to obtain precirrhotic chronic
liver injury in seven of the rabbits, which was confirmed as
portal fibrosis on the histopathologic examination. 
When Gd-EOB-DTPA, gadolinium-diethylenetriamine-
pentaacetic-acid (DTPA), is covalently linked to the
lipophilic ethoxybenzyl (EOB) moiety ([4S]-4-[4-ethoxy-
benzyl]-3,6,9-tris[carboxylatomethyl]-3,6,9-triazaunde-
candioic acid) then EOB-DTPA is formed: this is a newly
developed MR contrast agent with a preferential uptake by
hepatocytes (22). In previously reported animal studies,
Gd-EOB DTPA was cleared from the body by two elimina-
tion routes: one route is the receptor-specific uptake via
the organic anion transporter (it is also called glutathione-
S-transferase), in the hepatocytes with subsequent biliary
excretion. The other route is via glomerular filtration in the
kidneys with subsequent urinary excretion (22-24). The
percentage of hepatobiliary elimination has been shown to
differ widely between species (eg, rat, 63-80%; monkeys,
32-34%) (22). The preclinical safety evaluations did not
demonstrate any potential for toxic effects on the liver or
other tissues after the intravenous injection of Gd-EOB-
DTPA (22, 25-26). The results of animal experiments have
proven there was complete elimination of the agent, even
in the cases where there was severe impairment of hepato-
biliary or renal excretory function; the remaining elimina-
tion pathway may fully compensate for the virtual absence
of the other pathway (23, 27). In a human study, Gd-EOB-
DTPA was generally well tolerated with only mild side
effects in 22% of the patients who received the contrast
agent. No serious adverse effects or significant biochemical
changes, including the liver enzymes, were found (28).
Another advantage of this new contrast agent is that it can
be administered as a bolus, and this makes it very suitable
for use in dynamic MR imaging studies. During the first
minutes after administration of the contrast agent, liver
lesions should show enhancement in accordance with their
vascularization and the extent of their extracellular space.
Thus, Gd-EOB-DTPA shows promise for improving both
the differential diagnosis of liver lesions and the detection
of liver metastases in a single examination. Another
interesting aspect of Gd-EOB-DTPA is its hepatobiliary
excretion and the resultant contrast enhancement of the
biliary system. A preclinical study reported that MR
images obtained with use of Gd-EOB-DTPA allowed for
monitoring the excretory function of hepatocytes (29).
After intravenous injection, Gd-EOB-DTPA, which is
bound to albumin due to its lipophilic nature, is gradually
taken up by hepatocytes and eventually excreted by the
biliary pathway. Further, Gd-EOB-DTPA does not change
its chemical structure during circulation (22). Owing to
these characteristics, Gd-EOB-DTPA could be used not
only for hepatic imaging, but also for the measurement of
hepatic function. 
In this study, we used Gd-EOB-DTPA as a tracer, and
the sequential liver MR signal change that corresponded to
the tracer concentration at the last point was acquired by
the dynamic MR technique. The sequential MR signal
change of the aorta, which was assumed to be the tracer
concentration at the initial point (f[t]), was also acquired by
the dynamic MR technique. Theoretically, the tracer
concentration at the initial point, f(t), should be measured
at the feeding artery of the liver. However, when we
considered the possibilities of the change MR signal regard-
less of tracer concentration such as angiographic effect, it
was practical to measure and define the signal change of
the aorta as the tracer concentration at the initial point.
Therefore, after measuring f(t) and g(t), the moving
function h(t) of liver could be estimated by deconvolution
analysis. Since h(t) reflects the hepatocyte uptake of Gd-
EOB-DTPA, the liver function can be quantitatively and
noninvasively measured through a deconvolution analysis.
In order to calculate the deconvolution, either the matrix
method or the Fourier transform method can be used.
Fourier transform is known to be more accurate, and it is
the technique for transforming the data from the time
domain into the frequency domain or vice versa. By
applying Fourier transform, the convolution integral of
equation becomes a simple multiplicity equation.
However, the tracer concentration is practically measured
during a finite time interval and then abruptly terminated.
This abrupt termination of input data introduces a high
frequency artifact into the Fourier transform. In this study,
we introduced a modified Fourier transform technique.
With the modified Fourier transform technique, both the
aorta and liver curves are extended to many times their
original length by appending a low-frequency, smoothly
tapering curve to the original data series to compensate for
MRI Using Gd-EOB-DTPA Liver Function Evaluation
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tion of data. Finally, the inverse Fourier transform of f(t)
and g(t) was performed and the resultant deconvoluted
curve representing the true liver response h(t), was
obtained. An exponential curve of the best fit was applied
to liver response h(t), and the y-intercept of this curve was
used to represent the HEF.
The Gd-EOB-DTPA HEF values calculated by deconvo-
lution analysis of the time-intensity curves obtained from
dynamic MRI were lower in the rabbits after they had
been treated with CCl4 than in those HEF values before
administration of CCl4. The increase of liver enzyme
levels had a relatively wide range (AST, 138.4±50.5 IU;
ALT, 172.0±71.6 IU/L) and it showed low correlation
with the changes of the ICG R15 (AST, correlation coeffi-
cient = -0.252, p = 0.568; ALT, correlation coefficient =
0.310, p = 0.499). These results are probably explained by
the lack of specificity and directness of the liver enzyme
quantification. Yet the HEFs obtained from Gd-EOB-
DTPA MRI showed a relatively narrow range of abnormal-
ity and a high correlation with the changes of the ICG R15
(correlation coefficient = 0.965, p = 0.000). The
histopathologic results and ICG R15 values were compati-
ble with those values resulting from chronic liver disease. 
In conclusion, deconvolution analysis with a liver-specific
MR agent is a noninvasive technique for the quantitative
evaluation of liver function, and this technique may also be
valuable for detecting subtle changes in pathophysiology
and for comparison of sequential studies. It could be a
promising alternative for the noninvasive determination of
hepatic function in those patients with liver disease. 
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